NASDAQ · JWEL

Jowell Global Ltd.

$1.80 +$0.01 (+0.56%) 1D Market open

Key Metrics

$4.25M
Market cap
P/E · TTM
Revenue · TTM
Net income
EPS · TTM
Dividend yield
Free cash flow −$1.54M
Beta · 1Y 0.32
EBITDA · TTM
Gross margin

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 24
    From its Jun 17 high, the share price fell 32%.

    Peak close $2.65 on Jun 17; trough close $1.79 on Jul 24. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -32%
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • May 29
    The stock moved +13.9% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, May 29
  • Feb 24
    The stock moved +19.9% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Feb 24

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$4.25M
Enterprise value−$1.30M
Shares outstanding2.4M
52-wk range$1.47 – $3.00
Avg volume · 20D56.8K
Net cash $5.55M
Book value / share$4.82
ExchangeNASDAQ
About Jowell Global Ltd.
IPO dateMar 17, 2021
Employees174

Jowell Global Ltd is a cosmetics, health, nutritional supplements, and household products e-commerce platform in China. The company offers its branded products to customers and also sells and distributes products from other companies on its platform.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S
P/FCF
EV/EBITDA
EV/Sales
Graham №

Profitability

Gross
Operating
Net
FCF
ROE / ROIC — · —

Financial Health

Current ratio1.68
Quick ratio1.05
Debt / equity0.00
Debt / EBITDA
Net cash $5.55M
Working capital$6.46M

Cash Flow · TTM

Operating CF −$1.53M
Capex −$12.41K
Free cash flow −$1.54M
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

3 / 9
Weak fundamentals · 3 of 9 signals passing

Altman Z-Score

Insufficient balance-sheet inputs

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2025-12-31 · computed by TickerWolf from SEC filings